{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T20:53:15Z","timestamp":1782507195343,"version":"3.54.5"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":46,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46412-1","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T03:08:15Z","timestamp":1775790495000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic Potential of Repurposing non-\u03b2-lactam Compounds as Class A serine \u03b2-lactamases Inhibitor:\u00a0Insights from MolecularDocking, Molecular Dynamics Simulations and Antimicrobial Potentiation"],"prefix":"10.1038","volume":"16","author":[{"given":"Mohammed Sulieman","family":"Abdalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somenath","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mujtba Osman","family":"Sulieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif Adil","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Osman","family":"Noorelhuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Fathelrahman","family":"Elkhidir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipta","family":"Sardar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nooh Mohamed","family":"Hajhamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal A.","family":"Awad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufyan Awdelkarim","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun-Gu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najem Aldin M.","family":"Aldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"46412_CR1","doi-asserted-by":"crossref","unstructured":"Muteeb, G., Rehman, M. T., Shahwan, M. & Aatif, M. Origin of antibiotics and antibiotic resistance, and their impacts on drug development: A narrative review. Pharmaceuticals (Basel) 16 (2023).","DOI":"10.20944\/preprints202306.1921.v1"},{"key":"46412_CR2","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3389\/fimmu.2018.01068","volume":"9","author":"A Tagliabue","year":"2018","unstructured":"Tagliabue, A. & Rappuoli, R. Changing priorities in vaccinology: Antibiotic resistance moving to the top. Front. Immunol. 9, 1068 (2018).","journal-title":"Front. Immunol."},{"key":"46412_CR3","doi-asserted-by":"publisher","first-page":"1848","DOI":"10.1093\/cid\/ciac506","volume":"75","author":"R Pai Mangalore","year":"2022","unstructured":"Pai Mangalore, R., Ashok, A., Lee, S. J., Romero, L., Peel, T. N., Udy, A. A., & Peleg, A. Y. (2022). Beta-lactam antibiotic therapeutic drug monitoring in critically ill patients: a systematic review and meta-analysis. Clinical Infectious Diseases, 75(10), 1848-1860.\u200f","journal-title":"Clin. Infect. Dis."},{"key":"46412_CR4","unstructured":"Pandey, N. & Cascella, M. Beta-Lactam Antibiotics (2025)."},{"key":"46412_CR5","doi-asserted-by":"crossref","unstructured":"Narendrakumar, L., Chakraborty, M., Kumari, S., Paul, D. & Das, B. \u03b2-Lactam potentiators to re-sensitize resistant pathogens: Discovery, development, clinical use and the way forward. Front Microbiol. 13 (2023).","DOI":"10.3389\/fmicb.2022.1092556"},{"key":"46412_CR6","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1128\/AAC.01009-09","volume":"54","author":"K Bush","year":"2010","unstructured":"Bush, K. & Jacoby, G. A. Updated functional classification of \u03b2-lactamases. Antimicrob. Agents Chemother. 54, 969\u2013976 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"46412_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1128\/CMR.00019-15","volume":"29","author":"A Philippon","year":"2016","unstructured":"Philippon, A., Slama, P., D\u00e9ny, P., Labia, R. A. Structure-based: Classification of class A \u03b2-lactamases, a broadly diverse family of enzymes. Clin. Microbiol. Rev. 29, 29\u201357 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"46412_CR8","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3390\/biomedicines11112937","volume":"11","author":"A Husna","year":"2023","unstructured":"Husna, A., Rahman, M. M., Badruzzaman, A. T. M., Sikder, M. H., Islam, M. R., Rahman, M. T., ... & Ashour, H. M. (2023). Extended-spectrum \u03b2-lactamases (ESBL): challenges and opportunities. Biomedicines, 11(11), 2937.\u200f","journal-title":"Biomedicines"},{"key":"46412_CR9","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3855\/jidc.21781","volume":"20(02)","author":"Mohammed Salim","year":"2026","unstructured":"Salim, M. A., Diler, S. B., K\u00f6kl\u00fc, R., \u00d6ztr\u00fck, A., Polat, F., Hajhamed, N. M., & Mohamed, N. S. (2026). Prevalence and drug resistance patterns of ESKAPE pathogens in Nigde, T\u00fcrkiye. The Journal of Infection in Developing Countries, 20(02), 208-218.\u200f","journal-title":"The Journal of Infection in Developing Countries"},{"key":"46412_CR10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1098\/rstb.1980.0049","volume":"289","author":"RP Ambler","year":"1980","unstructured":"Ambler, R. P. The structure of \u03b2-lactamases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 289, 321\u2013331 (1980).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"46412_CR11","doi-asserted-by":"crossref","unstructured":"Castanheira, M., Simner, P. J. & Bradford, P. A. Extended-spectrum \u03b2-lactamases: An update on their characteristics, epidemiology and detection. JAC Antimicrob. Resist. 3 (2021).","DOI":"10.1093\/jacamr\/dlab092"},{"key":"46412_CR12","doi-asserted-by":"crossref","unstructured":"Liakopoulos, A., Mevius, D. & Ceccarelli, D. A. Review of SHV extended-spectrum \u03b2-lactamases: Neglected yet ubiquitous. Front Microbiol. 7 (2016).","DOI":"10.3389\/fmicb.2016.01374"},{"key":"46412_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1128\/AAC.00930-10","volume":"55","author":"W Ke","year":"2011","unstructured":"Ke, W., Sampson, J. M., Ori, C., Prati, F., Drawz, S. M., Bethel, C. R., ... & Van Den Akker, F. (2011). Novel insights into the mode of inhibition of class A SHV-1 \u03b2-lactamases revealed by boronic acid transition state inhibitors. Antimicrobial agents and chemotherapy, 55(1), 174-183.\u200f","journal-title":"Antimicrob. Agents Chemother."},{"key":"46412_CR14","doi-asserted-by":"publisher","first-page":"e0136813","DOI":"10.1371\/journal.pone.0136813","volume":"10","author":"NP Krishnan","year":"2015","unstructured":"Krishnan, N. P., Nguyen, N. Q., Papp-Wallace, K. M., Bonomo, R. A. & van den Akker, F. Inhibition of klebsiella \u03b2-lactamases (SHV-1 and KPC-2) by avibactam: A structural study. PLoS One. 10, e0136813 (2015).","journal-title":"PLoS One"},{"key":"46412_CR15","unstructured":"Davies, O. L. WHO publishes list of bacteria for which new antibiotics are urgently needed (2017). https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed"},{"key":"46412_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41579-019-0288-0","volume":"18","author":"U Theuretzbacher","year":"2020","unstructured":"Theuretzbacher, U., Outterson, K., Engel, A. & Karl\u00e9n, A. The global preclinical antibacterial pipeline. Nat. Rev. Microbiol. 18, 275\u2013285 (2020).","journal-title":"Nat. Rev. Microbiol."},{"key":"46412_CR17","doi-asserted-by":"publisher","first-page":"a025247","DOI":"10.1101\/cshperspect.a025247","volume":"6","author":"K Bush","year":"2016","unstructured":"Bush, K. & Bradford, P. A. \u03b2-lactams and \u03b2-lactamase inhibitors: An overview Cold Spring Harb Perspect. Med. 6, a025247 (2016).","journal-title":"Cold Spring Harb Perspect. Med."},{"key":"46412_CR18","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1039\/C8MD00342D","volume":"9","author":"KHME Tehrani","year":"2018","unstructured":"Tehrani, K. H. M. E. & Martin N. I. \u03b2-lactam\/\u03b2-lactamase inhibitor combinations: an update. Medchemcomm 9, 1439\u20131456 (2018).","journal-title":"Medchemcomm"},{"key":"46412_CR19","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1021\/acsinfecdis.0c00656","volume":"7","author":"AB Shapiro","year":"2021","unstructured":"Shapiro, A. B. & Gao, N. Interactions of the diazabicyclooctane serine \u03b2-lactamase inhibitor ETX1317 with target enzymes. ACS Infect. Dis. 7, 114\u2013122 (2021).","journal-title":"ACS Infect. Dis."},{"key":"46412_CR20","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1093\/cid\/ciw378","volume":"63","author":"FM Wagenlehner","year":"2016","unstructured":"Wagenlehner, F. M., Sobel, J. D., Newell, P., Armstrong, J., Huang, X., Stone, G. G., ... & Gasink, L. B. (2016). Ceftazidime-avibactam versus doripenem for the treatment of complicated urinary tract infections, including acute pyelonephritis: RECAPTURE, a phase 3 randomized trial program. Clinical Infectious Diseases, 63(6), 754-762.\u200f","journal-title":"Clin. Infect. Dis."},{"key":"46412_CR21","doi-asserted-by":"publisher","first-page":"12019","DOI":"10.2147\/DDDT.S576701","volume":"19","author":"A Al Khzem","year":"2025","unstructured":"Al Khzem, A. & Wali, S. Drug repurposing as an effective drug discovery strategy: A critical review. Drug Des. Dev. Ther. 19, 12019\u201312034 (2025).","journal-title":"Drug Des. Dev. Ther."},{"key":"46412_CR22","doi-asserted-by":"publisher","first-page":"116833","DOI":"10.1016\/j.ejmech.2024.116833","volume":"279","author":"M Aggarwal","year":"2024","unstructured":"Aggarwal, M., Patra, A., Awasthi, I., George, A., Gagneja, S., Gupta, V., ... & Sharma, P. (2024). Drug repurposing against antibiotic resistant bacterial pathogens. European Journal of Medicinal Chemistry, 279, 116833.\u200f","journal-title":"Eur. J. Med. Chem."},{"key":"46412_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s40121-020-00286-6","volume":"9","author":"JY Wu","year":"2020","unstructured":"Wu, J. Y., Srinivas, P., Pogue, J. M. Cefiderocol: A novel agent for the management of multidrug-resistant gram-negative organisms. Infect. Dis. Ther. 9, 17\u201340 (2020).","journal-title":"Infect. Dis. Ther."},{"key":"46412_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1021\/acsinfecdis.7b00071","volume":"3","author":"RJ Melander","year":"2017","unstructured":"Melander, R. J. & Melander, C. The challenge of overcoming antibiotic resistance: An adjuvant approach? ACS Infect. Dis. 3, 559\u2013563 (2017).","journal-title":"ACS Infect. Dis."},{"key":"46412_CR25","doi-asserted-by":"crossref","unstructured":"Kumar, V., Yasmeen, N., Pandey, A., Ahmad Chaudhary, A., Alawam, A. S., Ahmad Rudayni, H., ... & Shahid, M. (2023). Antibiotic adjuvants: synergistic tool to combat multi-drug resistant pathogens. Frontiers in Cellular and Infection Microbiology, 13, 1293633.\u200f.","DOI":"10.3389\/fcimb.2023.1293633"},{"key":"46412_CR26","doi-asserted-by":"crossref","unstructured":"Bajaj, P., Singh, N. S. & Virdi, J. S. Escherichia coli \u03b2-lactamases: What really matters. Front. Microbiol. 7 (2016).","DOI":"10.3389\/fmicb.2016.00417"},{"key":"46412_CR27","unstructured":"Chemical Computing Group ULC. Molecular Operating Environment (MOE). Preprint at (2024). https:\/\/www.chemcomp.com"},{"key":"46412_CR28","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., ... & Bryant, S. H. (2016). PubChem substance and compound databases. Nucleic acids research, 44(D1), D1202-D1213.\u200f","journal-title":"Nucleic Acids Res."},{"key":"46412_CR29","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1021\/acs.jcim.6b00174","volume":"56","author":"V Zoete","year":"2016","unstructured":"Zoete, V., Daina, A., Bovigny, C., Michielin, O. SwissSimilarity: A web tool for low to ultra high throughput ligand-based virtual screening. J. Chem. Inf. Model. 56, 1399\u20131404 (2016).","journal-title":"J. Chem. Inf. Model."},{"key":"46412_CR30","doi-asserted-by":"publisher","first-page":"27501","DOI":"10.1039\/D3RA04768G","volume":"13","author":"RMA Ebrahim","year":"2023","unstructured":"Ebrahim RMA, Abdelbagi A, Sulfab Y, Hamdi OAA, Shokri SA, Ali EA. Synthesis, characterization, molecular docking, and antimicrobial activities of dinuclear nickel(ii), palladium(ii), and platinum(iv) complexes. RSC Adv. 2023 Sep 14;13(39):27501-27511. doi: 10.1039\/d3ra04768g. PMID: 37720836; PMCID: PMC10501048.","journal-title":"RSC Adv."},{"key":"46412_CR31","doi-asserted-by":"publisher","first-page":"17374","DOI":"10.1039\/D0NJ04088F","volume":"44","author":"A Ghanem","year":"2020","unstructured":"Ghanem, A., Emara, H. A., Muawia, S., Abd El Maksoud, A. I., Al-Karmalawy, A. A., & Elshal, M. F. (2020). Tanshinone IIA synergistically enhances the antitumor activity of doxorubicin by interfering with the PI3K\/AKT\/mTOR pathway and inhibition of topoisomerase II: in vitro and molecular docking studies. New journal of chemistry, 44(40), 17374-17381.\u200f","journal-title":"New J. Chem."},{"key":"46412_CR32","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1021\/jp984217f","volume":"103","author":"WRP Scott","year":"1999","unstructured":"Scott, W. R., H\u00fcnenberger, P. H., Tironi, I. G., Mark, A. E., Billeter, S. R., Fennen, J., ... & Van Gunsteren, W. F. (1999). The GROMOS biomolecular simulation program package. The Journal of Physical Chemistry A, 103(19), 3596-3607.\u200f","journal-title":"J. Phys. Chem. A"},{"key":"46412_CR33","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/jcc.20945","volume":"29","author":"S Jo","year":"2008","unstructured":"Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM-GUI: A web\u2010based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859\u20131865 (2008).","journal-title":"J. Comput. Chem."},{"key":"46412_CR34","doi-asserted-by":"publisher","first-page":"43807","DOI":"10.1038\/srep43807","volume":"7","author":"MA Anwar","year":"2017","unstructured":"Anwar, M. A. & Choi, S. Structure\u2013activity relationship in TLR4 mutations: Atomistic molecular dynamics simulations and residue interaction network analysis. Sci. Rep. 7, 43807 (2017).","journal-title":"Sci. Rep."},{"key":"46412_CR35","doi-asserted-by":"publisher","first-page":"E683","DOI":"10.1503\/cmaj.221319","volume":"195","author":"F Morriello","year":"2023","unstructured":"Morriello, F. & Chapman, M. Epinephrine in anaphylaxis. Can. Med. Assoc. J. 195, E683\u2013E683 (2023).","journal-title":"Can. Med. Assoc. J."},{"key":"46412_CR36","doi-asserted-by":"publisher","DOI":"10.3238\/arztebl.2016.0477","author":"J M\u00f6ssner","year":"2016","unstructured":"M\u00f6ssner, J. The indications, applications, and risks of proton pump inhibitors. Dtsch. Arztebl Int. https:\/\/doi.org\/10.3238\/arztebl.2016.0477 (2016).","journal-title":"Dtsch. Arztebl Int."},{"key":"46412_CR37","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2885.2011.01327.x","volume":"35","author":"OA Chiesa","year":"2012","unstructured":"Chiesa OA, Li H, Kijak PJ, Li JX, Lancaster V, Smith ML, Heller DN, Thomas MH, Von Bredow J. Tissue\/fluid correlation study for the depletion of sulfadimethoxine in bovine kidney, liver, plasma, urine, and oral fluid. J Vet Pharmacol Ther. 2012 Jun;35(3):249-58. doi: 10.1111\/j.1365-2885.2011.01327.x. Epub 2011 Aug 11. PMID: 21831115.","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"46412_CR38","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJM198201283060405","volume":"306","author":"J Koch-Weser","year":"1982","unstructured":"Koch-Weser, J., Vidt, D. G., Bravo, E. L., Fouad, F. M. Captopril. N. Engl. J. Med. 306, 214\u2013219 (1982).","journal-title":"N. Engl. J. Med."},{"key":"46412_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.20473\/jmv.vol7.iss1.2024.19-32","volume":"7","author":"YR Mustika","year":"2024","unstructured":"Mustika, Y. R., Effendi, M. H., Puspitasari, Y., Plumeriastuti, H., Khairullah, A. R., & Kinasih, K. N. (2024). Identification of Escherichia coli Multidrug Resistance in Cattle in Abattoirs. Jurnal Medik Veterinar, 7(1).\u200f","journal-title":"J. Med. Vet."},{"key":"46412_CR40","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/j.jiph.2020.06.026","volume":"13","author":"TMS Dawoud","year":"2020","unstructured":"Dawoud, T. M., Syed, A., Maurya, A. K., Ahmad, S. S., Rabbani, Q., Alyousef, A. A., ... & Daglia, M. (2020). Incidence and antimicrobial profile of extended-spectrum \u03b2-lactamase producing Gram-negative bacterial isolates: An in-vitro and statistical analysis. Journal of infection and public health, 13(11), 1729-1733.\u200f","journal-title":"J. Infect. Public. Health"},{"key":"46412_CR41","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1128\/JCM.43.5.2545.2005","volume":"43","author":"JE Mortensen","year":"2005","unstructured":"Mortensen, J. E., Bernier, M., Gray, L. D., Dolan, S., Hanson, N. D., Moland, E. S., & Abdalhamid, B. (2005). New quality control strain for use in routine testing for production of extended-spectrum beta-lactamases by Enterobacteriaceae. Journal of clinical microbiology, 43(5), 2545-2545.\u200f","journal-title":"J. Clin. Microbiol."},{"key":"46412_CR42","doi-asserted-by":"crossref","unstructured":"Dutta, S., Biswas, I., Goswami, S. & Verma, A. Real-world application of molecular docking in drug discovery. in Revolutionizing Drug Discovery: Cutting-Edge Computational Techniques (eds. Verma, Swati Ajmer Singh, Grewal, N. & Nimesh Hemlata), Vol. 103 393\u2013413 (Elsevier, New York, 2025).","DOI":"10.1016\/bs.apha.2025.01.013"},{"key":"46412_CR43","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1128\/AAC.03057-14","volume":"58","author":"SD Lahiri","year":"2014","unstructured":"Lahiri, S. D., Johnstone, M. R., Ross, P. L., McLaughlin, R. E., Olivier, N. B., & Alm, R. A. (2014). Avibactam and class C \u03b2-lactamases: mechanism of inhibition, conservation of the binding pocket, and implications for resistance. Antimicrobial agents and chemotherapy, 58(10), 5704-5713.\u200f","journal-title":"Antimicrob. Agents Chemother."},{"key":"46412_CR44","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1021\/acs.jcim.2c01444","volume":"63","author":"Y Maruyama","year":"2023","unstructured":"Maruyama, Y., Igarashi, R., Ushiku, Y. & Mitsutake, A. Analysis of protein folding simulation with moving root mean square deviation. J. Chem. Inf. Model. 63, 1529\u20131541 (2023).","journal-title":"J. Chem. Inf. Model."},{"key":"46412_CR45","doi-asserted-by":"publisher","first-page":"7321","DOI":"10.1080\/07391102.2023.2239932","volume":"42","author":"M Pritam","year":"2024","unstructured":"Pritam, M., Dutta, S., Medicherla, K. M., Kumar, R. & Singh, S. P. Computational analysis of spike protein of SARS-CoV-2 (Omicron variant) for development of peptide-based therapeutics and diagnostics. J. Biomol. Struct. Dyn. 42, 7321\u20137339 (2024).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"46412_CR46","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.1021\/acs.jctc.9b00483","volume":"15","author":"EP Barros","year":"2019","unstructured":"Barros, E. P., Schiffer, J. M., Vorobieva, A., Dou, J., Baker, D., & Amaro, R. E. (2019). Improving the efficiency of ligand-binding protein design with molecular dynamics simulations. Journal of chemical theory and computation, 15(10), 5703-5715.\u200f","journal-title":"J. Chem. Theory Comput."},{"key":"46412_CR47","doi-asserted-by":"crossref","unstructured":"Dutta, S., Sri Pushan, S., Ghosh, R., Jose, M. & Pritam, M. In silico study of antiviral phytochemicals for the potential drug development against wild-type and omicron variants of SARS-CoV-2. Curr Pharm. Biotechnol. 27 (2025).","DOI":"10.2174\/0113892010251819241120050831"},{"key":"46412_CR48","doi-asserted-by":"publisher","first-page":"100084","DOI":"10.1016\/j.amolm.2025.100084","volume":"5","author":"L Mahamba","year":"2025","unstructured":"Mahamba, L., Isa, M. A. & Kappo, A. P. In silico identification of potential inhibitors for the universal stress G4LZI3 protein from Schistosoma mansoni using molecular docking and molecular dynamics simulation analyses. Aspects Mol. Med. 5, 100084 (2025).","journal-title":"Aspects Mol. Med."},{"key":"46412_CR49","doi-asserted-by":"crossref","unstructured":"Pritam, M., Dutta, S. & Kumar, R. Identification of potential necroptosis inhibitors using pharmacophore model: An in-silico approach. Curr. Proteom. 22 (2025).","DOI":"10.2174\/0115701646327161241205072125"},{"key":"46412_CR50","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s00894-009-0454-9","volume":"15","author":"E Durham","year":"2009","unstructured":"Durham, E., Dorr, B., Woetzel, N., Staritzbichler, R. & Meiler, J. Solvent accessible surface area approximations for rapid and accurate protein structure prediction. J. Mol. Model. 15, 1093\u20131108 (2009).","journal-title":"J. Mol. Model."},{"key":"46412_CR51","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1042\/bj2710399","volume":"271","author":"F Jacob","year":"1990","unstructured":"Jacob, F., Joris, B., Lepage, S., Dusart, J. & Fr\u00e8re, J. M. Role of the conserved amino acids of the \u2018SDN\u2019 loop (Ser130, Asp131 and Asn132) in a class A \u03b2-lactamase studied by site-directed mutagenesis. Biochem. J. 271, 399\u2013406 (1990).","journal-title":"Biochem. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46412-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T11:03:02Z","timestamp":1779793382000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46412-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46412"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46412-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"16164"}}